514 related articles for article (PubMed ID: 32043519)
21. Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses.
He Y; Cao Y; Wang X; Jisiguleng W; Tao M; Liu J; Wang F; Chao L; Wang W; Li P; Fu H; Xing W; Zhu Z; Huan Y; Yuan H
Comput Math Methods Med; 2021; 2021():5548918. PubMed ID: 34055036
[TBL] [Abstract][Full Text] [Related]
22. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
[TBL] [Abstract][Full Text] [Related]
23. CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis.
Fan Y; He L; Wang Y; Fu S; Han Y; Fan J; Wen Q
Front Mol Biosci; 2020; 7():616190. PubMed ID: 33575272
[No Abstract] [Full Text] [Related]
24. Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases.
Yan S; Jiao X; Zou H; Li K
Diagn Pathol; 2015 Jun; 10():62. PubMed ID: 26047809
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of HMGB3 and its prognostic value in breast cancer.
Zhou X; Zhang Q; Liang G; Liang X; Luo B
Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
[TBL] [Abstract][Full Text] [Related]
26. LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA).
Jin TY; Saindane M; Park KS; Kim S; Nam S; Yoo Y; Yang JH; Yun I
Medicine (Baltimore); 2021 Aug; 100(33):e26896. PubMed ID: 34414945
[TBL] [Abstract][Full Text] [Related]
27. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
Yu Z; Cheng L; Liu X; Zhang L; Cao H
Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
[No Abstract] [Full Text] [Related]
28. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
Qiu Y; Lu G; Wu Y
J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
31. MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.
Hunt BG; Wicker CA; Bourn JR; Lower EE; Takiar V; Waltz SE
Breast Cancer Res Treat; 2020 Jun; 181(3):529-540. PubMed ID: 32342233
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer.
Chen YZ; Zuo D; Ren HL; Fan SJ; Ying G
Technol Cancer Res Treat; 2019; 18():1533033819892260. PubMed ID: 31808361
[TBL] [Abstract][Full Text] [Related]
33. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
34. Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
Yang W; Wu X; Zhou F
Med Sci Monit; 2021 Feb; 27():e928919. PubMed ID: 33637669
[TBL] [Abstract][Full Text] [Related]
35. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
[TBL] [Abstract][Full Text] [Related]
36. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
Hou MF; Chen PM; Chu PY
BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
[TBL] [Abstract][Full Text] [Related]
37. Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer.
Brodsky AS; Xiong J; Yang D; Schorl C; Fenton MA; Graves TA; Sikov WM; Resnick MB; Wang Y
BMC Cancer; 2016 Apr; 16():274. PubMed ID: 27090210
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
Front Immunol; 2023; 14():955949. PubMed ID: 37006317
[TBL] [Abstract][Full Text] [Related]
39. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
40. High expression COL10A1 promotes breast cancer progression and predicts poor prognosis.
Zhou W; Li Y; Gu D; Xu J; Wang R; Wang H; Liu C
Heliyon; 2022 Oct; 8(10):e11083. PubMed ID: 36281404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
